Sagent Pharmaceuticals is expanding ready-to-use imaging agents with Zyogreen, an FDA-approved indocyanine green injection supplied as a sterile solution that requires no reconstitution. Conventional ICG products are typically provided as lyophilized powders that clinicians must prepare before administration. Zyogreen removes this step while supporting fluorescence-guided procedures and diagnostic imaging across vascular, gastrointestinal, transplant, reconstructive, gynecologic, and ophthalmic applications. The product is commercially available through Sagent’s U.S. distribution network.
For Sagent, the launch expands its specialty pharmaceutical portfolio while addressing workflow efficiency for hospitals and surgical teams. The ready-to-use format could reduce preparation demands and make ICG more convenient to incorporate into clinical workflows. Zyogreen also joins Bludigo in Sagent’s surgical and diagnostic visualization portfolio, giving the company a broader presence in medical dyes while its partnership with Provepharm supports nationwide distribution and product availability.
Image Credit: Sagent Pharmaceuticals
Why This Trend Is Growing
- Ready-to-use Injectables
- Pre-prepared sterile formulations reduce pharmacy handling steps and create openings for differentiated hospital products built around speed, consistency, and lower preparation complexity.
- Fluorescence-guided Surgery
- Expanded use of imaging dyes in operating rooms is reshaping procedural visibility, enabling new combinations of diagnostics, surgical tools, and specialty pharmaceuticals.
- Workflow-centric Pharmaceuticals
- Medication formats designed around clinical efficiency highlight a shift toward products that compete on operational value as much as therapeutic performance.
Industries Being Reshaped
- Specialty Pharmaceuticals
- Companies in niche injectable and diagnostic portfolios can use formulation convenience as a point of separation in mature clinical categories.
- Medical Imaging
- Demand for real-time visualization in surgery and diagnostics supports growth in agent-device ecosystems that improve precision across multiple specialties.
- Hospital Supplies
- Sterile, ready-to-administer products reflect an opportunity for suppliers to address staff constraints, reduce preparation variability, and simplify procedural logistics.
